Several metabolic perturbations have been reported in SMA animal models and patients [74], highlighting an existing metabolically stressed environment that could contribute to the aberrant KLF15 activity in SMA muscle. The gene discussed is KLF15; the disease is proximal spinal muscular atrophy.